David Snead, Ph.D., is the Director of Research at Medicines for All. He uses his expertise in process development to address problems in the pharmaceutical and commodity chemical industries. He comes to VCU from Merck where he applied continuous flow technology to solve complex problems in API process development. David developed his skills in continuous synthesis as a postdoc at MIT in the early days of the Pharmacy on Demand project. Prior to joining Merck, he worked in front-end innovation to identify and develop new business opportunities for GP Chemicals resulting in executive level sponsorship for commercialization of two projects. He holds a B.S. in chemistry from UNC-CH and a Ph.D. in organic chemistry from the University of Florida.
Tai holds BSc and MPhil degrees from the University of Hong Kong, and PhD in organic chemistry from Imperial College London on a British Commonwealth scholarship. He completed his postdoctoral training in organic synthesis at the Scripps Research Institute. Tai worked as a process chemist in the pharmaceutical industry for 18 years (DuPont Pharmaceutical, BMS, and Incyte). He was senior director of process chemistry at Incyte prior to joining the Clinton Health Access Initiative as scientific director in 2015.
Marek Buchman Ph.D. recently joined Medicines for All Institute as a Senior Research Scientist. Originally from Slovakia, Dr. Buchman obtained his MChem degree from the University of Oxford followed by his PhD studies with Prof. K.C. Nicolaou at Rice University in Houston, TX in the field of total synthesis of complex biologically active natural products such as novel anticancer agents and antibiotics. Before joining M4All, he was a post-doctoral research fellow at the pharmaceutical giant AbbVie in North Chicago, where he worked on the development of new methodologies for the synthesis of pharmaceutically relevant scaffolds.
Justina Burns, Ph.D. generates analytical chemistry methods to support process development at the Medicines for All Institute. Previously she worked in contract research supporting a variety of projects which included sample preparation/analysis, report writing and training. Additionally, Justina worked in the Mass Spectrometry Center at the University of South Carolina focusing on ICP-MS. She holds a B.S. in chemistry from University of Pittsburgh, Johnstown and a Ph.D. in analytical environmental chemistry from the University of South Carolina.
Flavio Cardoso, Ph.D., is a research scientist at Medicines for All Institute working on process development of APIs and/or key building blocks. Prior to joining M4ALL, he worked at Libbs Pharmaceuticals as R&D Coordinator where he gained experience in the development of synthetic processes for the manufacture of generic APIs. He holds a Ph.D. in organic chemistry from the University of Florida, where he designed and applied StackPhos, a new chiral biaryl heterocyclic ligand for enantioselective catalysis. Dr. Cardoso obtained his B.S. at UNICAMP (Brazil), where he applied palladium catalyzed cross-coupling reactions for the synthesis of biologically active compounds.
Daniel W. Cook, PhD is an analytical chemist within the Medicines for All Institute where he utilizes his expertise in separation sciences and chemometrics to develop and implement analytical methods to support the Institute’s various projects. He holds a B.S in chemistry from Randolph-Macon College in Ashland, VA and a Ph.D. in chemistry from VCU. Prior to his current role at M4ALL, he held a postdoctoral fellowship at VCU in the Chemical and Life Science Engineering department working on both the Pharmacy on Demand project under Dr. Thomas Roper and M4ALL under Dr. Frank Gupton. He transitioned into his current role in early 2019.
Vijayagopal Gopalsamuthiram, Ph.D., is an active member of the process development team working on the 3TC project. He is also is responsible for performing reproducibility studies in demo batches for DTG and in preparing comprehensive paper studies for forthcoming projects. Previously, Vijay was a team leader in process research at Syngenta and contributed in early stage process scouting and process optimization towards various agrochemical candidates. He brings extensive chemical discovery experience through his stint at DuPont and was a researcher working in targeted drug delivery at the University of Minnesota-Twin cities recently. He holds a Ph.D. in organic chemistry from Michigan State University.
Ryan Nelson, Ph.D., is a research scientist who joined the M4ALL team in the summer of 2019. His contributions to the group range from on-paper route development to benchtop route scouting and scale up. Previously, Ryan was a faculty member at Bowdoin and Bates Colleges in Maine, where he taught a variety of chemistry courses and contributed to several collaborative research projects. Ryan received his bachelor’s degree from Gustavus Adolphus College and his Ph.D. from the University of Wisconsin-Madison. He also held post-doctoral research positions at Argonne National Laboratory and University of California, Santa Barbara.
Michael Beiro received his Bachelor’s in Mechanical Engineering from VCU in 2018, and has been working on research projects in the Roper group since before his graduation. Initially brought on to build prototype devices for pharmacy supply chain management, his role has expanded to provide mechanical engineering support to the group’s primary efforts around continuous pharmaceutical manufacturing research. He specializes in mechatronics and automation, but his work within the Pharmaceutical Engineering lab has included IoT rapid prototyping, structural, fluid, and thermal simulations, product development and commercialization, entrepreneurship, and designing novel equipment for continuous flow manufacturing.